Earnings calendar/DNLI
Denali Therapeutics Inc. (DNLI)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.41
Street estimate
Revenue target
$12.3M
Street estimate
Trailing EPS (avg 4Q)
$-0.70
Beat rate last 4: 75%
Latest EPS YoY
+5.6%
vs 2025-08-11
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
$3.6M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS miss
EPS actual / est
$-0.68 / $-0.51
-32.5%
Revenue actual / est
$3.6M / $2.2M
+67.3%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.41 | Pending | — | $12.3M | Pending | — |
| 8/6/2026 | $-0.51 | $-0.68 | -32.5% | $2.2M | $3.6M | +67.3% |
| 5/11/2026upcoming | $-0.73 | Pending | — | $2.6M | Pending | — |
| 5/7/2026 | $-0.73 | $-0.69 | +5.5% | $2.6M | Pending | — |
| 5/5/2026 | $-0.73 | $-0.69 | +5.5% | $2.6M | Pending | — |
| 2/26/2026 | $-0.75 | $-0.73 | +2.7% | $3.1M | Pending | — |
| 11/6/2025 | $-0.76 | $-0.74 | +2.6% | $2.9M | Pending | — |
| 8/11/2025 | $-0.74 | $-0.72 | +2.7% | $5.6M | Pending | — |
| 5/6/2025 | $-0.71 | $-0.78 | -9.9% | $3.0M | Pending | — |
| 2/27/2025 | $-0.75 | $-0.67 | +10.7% | $12.8M | Pending | — |
| 11/6/2024 | $-0.60 | $-0.63 | -5.0% | $11.6M | Pending | — |
| 8/1/2024 | $-0.68 | $-0.59 | +13.2% | $12.5M | Pending | — |
| 5/7/2024 | $-0.67 | $-0.68 | -1.5% | $14.0M | Pending | — |
| 2/27/2024 | $-0.82 | $-0.86 | -4.9% | $8.4M | $305.0M | +3548.8% |
| 11/7/2023 | $-0.83 | $-0.72 | +13.3% | $8.9M | $1.3M | -85.8% |
| 8/8/2023 | $-0.68 | $1.30 | +291.2% | $13.5M | $294.1M | +2085.2% |
| 5/8/2023 | $-0.71 | $-0.80 | -12.7% | $28.7M | $35.1M | +22.3% |
| 2/27/2023 | $-0.78 | $-0.75 | +3.8% | $13.1M | $10.3M | -21.6% |
| 11/3/2022 | $-0.83 | $-0.84 | -1.2% | $17.0M | $3.6M | -79.1% |
| 8/8/2022 | $-0.52 | $-0.48 | +7.7% | $44.7M | $52.5M | +17.5% |
| 5/5/2022 | $-0.47 | $-0.53 | -12.8% | $33.4M | $42.1M | +26.3% |
| 2/28/2022 | $-0.41 | $-0.62 | -51.2% | $44.8M | $12.5M | -72.1% |
| 11/4/2021 | $-0.51 | $-0.69 | -35.3% | $32.0M | $5.3M | -83.5% |
| 8/4/2021 | $-0.37 | $-0.50 | -35.1% | $22.9M | $22.9M | 0.0% |
| 5/3/2021 | $-0.37 | $-0.58 | -56.8% | $5.8M | $7.9M | +37.4% |
| 2/25/2021 | $0.01 | $1.91 | +24387.2% | $78.2M | $316.8M | +305.1% |
| 11/5/2020 | $3.57 | $-0.54 | -115.1% | $51.8M | $9.4M | -81.9% |
| 8/7/2020 | $-0.61 | $-0.56 | +8.2% | $6.3M | $5.8M | -6.7% |
| 5/7/2020 | $-0.57 | $-0.55 | +3.5% | $3.7M | $3.6M | -3.5% |
| 2/27/2020 | $-0.53 | $-0.56 | -5.7% | $4.8M | $4.7M | -3.4% |
| 11/6/2019 | $-0.53 | $-0.48 | +9.4% | $15.9M | $13.6M | -14.3% |
| 8/6/2019 | $-0.46 | $-0.61 | -32.6% | $3.2M | $4.2M | +32.6% |
| 5/8/2019 | $-0.37 | $-0.41 | -10.8% | $4.1M | $4.2M | +2.5% |
| 3/12/2019 | $-0.11 | $0.79 | +818.2% | $17.5M | $125.7M | +618.2% |
| 11/8/2018 | $-0.21 | $-0.38 | -81.0% | $786,184.21 | $1.2M | +52.0% |
| 8/9/2018 | $-0.19 | $-0.59 | -210.5% | $558,644.07 | $1.6M | +195.0% |
| 5/11/2018 | $-0.03 | $-0.26 | -766.7% | $73,961.54 | $641,000 | +766.7% |
| 3/19/2018 | $-0.20 | $-0.74 | -270.0% | — | $145.1M | — |
| 12/8/2017 | — | $-0.32 | — | — | Pending | — |
| 9/30/2017 | — | $-0.27 | — | — | Pending | — |
| 3/31/2017 | — | $-2.36 | — | — | Pending | — |
| 12/31/2016 | — | $-2.15 | — | — | Pending | — |
| 9/30/2016 | — | $-4.51 | — | — | Pending | — |
| 6/30/2016 | — | $-3.37 | — | — | Pending | — |
| 3/31/2016 | — | $-3.37 | — | — | Pending | — |